Kratom Paradise botanical product packages and shipping boxes in a desert warehouse scene

How to Verify MIT Tablets and Extracts During the 7-OH Scheduling Process

Record the item's physical format, label fields, source or finished-product documentation, and current rules without relying on marketing language. The same record-matching process applies to MIT chewable tablets and extract powders.

Product verification is separate from product use. The checklist below covers purchasing and document matching only; it does not provide serving instructions, effect comparisons, conversions, tapering information, or medical advice.

1. Record the complete product identity

  • Full product title.
  • Standard or bulk quantity lane.
  • Physical format: chewable tablet or extract powder.
  • Labeled MIT option or extract product line.
  • Flavor or unflavored option.
  • Tablet count or powder net weight.
  • SKU when shown.

Do not reduce the record to a single number. A 100mg selector, 90% product-line name, 25-tablet count, and 1g net weight identify different fields. Keeping them separate prevents a label field from being mistaken for an analytical result.

2. Identify what the document tested

Document relationship Useful statement Limit
Finished-product report The identified finished item or lot was submitted for the listed analyses Still limited to the identified sample and report scope
Source-material report The identified input material was submitted for the listed analyses Does not independently test the finished tablet or package
Shared product-line reference Related listings currently point to one source document Does not establish independent testing of every option or lot
No matching report No product-specific analytical statement should be made Marketing language cannot replace missing evidence

3. Match the identifiers

  1. Open the current product listing rather than an old screenshot.
  2. Write down the report or sample reference displayed by the store.
  3. Open the complete document and match the submitted sample name and sample ID.
  4. Confirm the report date and tested matrix.
  5. Confirm that any product-stage statement says source material or finished product accurately.
  6. Save the order date with the document reference because relationships can change.

4. Read 7-OH results with the method limits

A result such as ND must stay connected to the LOD, LOQ, units, and sample. The source-material report associated with the current 90% MIT-CH concentrate lists 7-OH as ND with a 0.025 ppm LOQ for sample 141690. That statement is more informative and more accurate than saying simply contains no 7-OH.

For a full explanation, read What ND Means on a 7-OH Lab Report.

5. Keep the tablet relationship precise

Kratom Paradise has confirmed that its current MIT chewable tablets are made using the 90% MIT-CH source concentrate associated with internal reference 141690. That permits a source-material relationship statement. It does not permit the report to be described as a finished-tablet test.

  • Acceptable: the tablet line uses the documented 90% MIT-CH source concentrate.
  • Acceptable: the source concentrate report lists 7-OH as ND under its stated method and limits.
  • Not established: the laboratory tested every finished tablet or flavor.
  • Not established: the selector value is an independently verified per-tablet assay.
  • Not established: the source report determines federal, state, or local legality.

6. Check the current regulatory document

The July 2026 DEA action is currently a notice-of-intent process. Use the DEA 7-OH Scheduling Tracker for the current status, threshold summary, and official-source links. Do not rely on a product page or social post as the controlling legal document.

Destination rules can differ from federal scheduling. State, county, city, shipping, payment, and retail rules may use different product definitions. A visible product page does not guarantee that an item can be shipped to every location.

7. Watch for overbroad badges and claims

  • FDA approved.
  • DEA compliant.
  • Guaranteed legal everywhere.
  • Schedule-proof.
  • Zero 7-OH without a qualified sample statement.
  • Same effect or equivalent strength.
  • Lab certified when the document reports a sample result rather than a certification.

8. Preserve the record after ordering

Keep the original product label, order confirmation, selected variant, report reference, and any printed lot information together. For larger tablet orders, the existing receiving checklist provides fields for package condition, count, option, flavor, and discrepancies.

When the document relationship changes

A different concentrate lot requires a new source reference. Finished-tablet testing would be a separate evidence layer and would not change what the older source report tested. If no current record matches an item, no report from a nearby product should be treated as a substitute.

A final verification pass

Before relying on a page, ask whether the selected item, linked record, submitted material, and date form one traceable chain. Then check whether every conclusion stays within that chain. A source result can support a qualified source statement; a finished-product result can support a qualified finished-product statement; neither alone supplies a medical conclusion, an effect comparison, or a guarantee about future lots.

Keep the original package identity attached to any saved record. A screenshot without the selected variant, a cropped report without its sample ID, or a note without the review date can break the chain later. Complete records are especially important when several flavors, counts, product lines, or source lots share similar names.

Continue with the Bulk MIT Tablet Receiving Checklist, MIT Products Guide, or MIT Product Documents & COA Center.

Official sources and further reading

This checklist supports product and document matching. It does not provide medical, serving, equivalency, or legal advice.

Written By : Kratom Paradise Editorial Team